Navigation Links
Of mice and men: new male contraceptives successful in rodents and humans
Date:9/28/2007

Pills, sponges, IUDs, diaphragms-- women have many options for planning their fertility, none of them quite perfect. But what if men want to help out? They have only two options -- vasectomy, which is usually permanent, and condoms, which are crucial for dating but get old in long-term relationships. Will men ever have a way to reliably make sure that nobody is every calling them "Daddy" before they are ready?

For decades, pundits have predicted new contraceptives for men within the next 5 to 10 years. But judging from work presented today at the second "Future of Male Contraception" conference, we may finally be getting closer. Some highlights from the second day of the conference:

- Researchers from the University of Washington tried a hormone regimen based on two products already available on the market. They used testosterone gel, which is marketed for men with low testosterone, plus a progestin shot used as a female contraceptive under the name "DepoProvera." The men got a shot once every 3 months and rubbed on a gel every day, and it worked well at knocking out sperm in 90% of them. However, men's opinions of the method varied widely: 6 dropped out, and of the remaining 38, half of them were satisfied or very satisfied, a third were dissatisfied or very dissatisfied, and the rest were undecided or had mixed feelings.

- Shepherd Medical Company announced the results of their very first U.S. study in men of the "Intra Vas Device" (a vasectomy alternative): after 6 months, 92% of the men had no sperm or almost no sperm. The Intra Vas Device blocks sperm in the vas deferens, the tube sperm swim through (the same tube that is cut in vasectomy). The set of plugs can be removed if a man changes his mind, so it is much easier to get sperm flowing again than after vasectomy. Animal studies have shown that fertility returns if the IVD is removed after short-term use, but that doesn't guarantee successful pregnancy afte
'/>"/>

Contact: Elaine Lissner
415-839-6304
Male Contraception Information Project
Source:Eurekalert

1

GOOD

Page: 1 2

Related biology technology :

1. Keys to Successful Densitometry
2. Critical factors for successful microarray and real-time PCR analyses
3. Successful PCR amplification and subcloning of a GC-rich DNA fragment
4. General Considerations for Successful Transfection Experiments
5. Designing a Successful qRT-PCR Experiment
6. Precursor miRNAs for Successful miRNA Functional Studies
7. Recommendations for Successful siRNA Library Screens
8. Setting up Successful siRNA Library Screens
9. Successful stabilization of gene expression profiles
10. Business Plan Contest produces successful grads
11. Embracing failure is a necessary step for successful entrepreneurs

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... , NEW YORK, Dec. 2 /PRNewswire-USNewswire/ ...sts, policy makers, and funders today convened to ...e funding strategies at the inaugural Partnering ...ington-based center of the Milken Institute, conve...tor collaborations needed to turn a scientific dis...
(Date:12/2/2009)... , LIBREVILLE, Gabon, December 2 /PRNews...Africa: Everyone,s Problem and Heritage" , ...ersity, 2-3 June 2010 the,Gabonese Republic is hos...bon) on the issue of safeguarding biological resou... government and state leaders, ministers,scientif...
(Date:12/2/2009)... , SINGAPORE, Dec. 2 S*...its novel oral JAK2 inhibitor, SB1518, at The Amer... Exposition in New Orleans. ,, Data will be pre...se-escalation trial of SB1518 detailing its safety... (PK/PD) profile in dose levels ranging from 100 t...
(Date:12/2/2009)... , SHANGHAI, Dec. 2 /PRNewswire-Asia/ ... markets are in turmoil and uncertainty is part of... the pharma industry has been,relatively immune to...ke a,vacation. , During the midst of the ...t Johnson & Johnson inaugurated an R&D cen...
Breaking Biology Technology:Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Libreville International Conference 2-3 June 2010 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3
...TI) (Nasdaq: CTIC ; MTAX) management will present...e on Tuesday, March 18 at 9:00 AM Pacific Time,(PT...nce Center., The presentation will also be webcas... the presentation. The webcast can be accessed at,... WBBA Invest Northwest Conference ...
...drian Seeman has received the American Chemical So...shing the field of structural DNA nanotechnology. ...izes outstanding contributions in the field of che...on. , Seeman, the Margaret and Herman Sokol Prof...he field of DNA nanotechnology--which is now pursu...
... March 19 at 10:00 AM EDT, CEDAR KNOLLS, N.J., Ma...S ) today announced its financial results for,the ... Emisphere will host a conference call to discuss ...March 19, 2008. A live webcast of the conference,c... at: http://www.emisphere.com .,The live conferen...
Other Biology Technology:Emisphere Technologies, Inc. Announces 2007 Fourth Quarter and Year End Financial Results 2Emisphere Technologies, Inc. Announces 2007 Fourth Quarter and Year End Financial Results 3Emisphere Technologies, Inc. Announces 2007 Fourth Quarter and Year End Financial Results 4Emisphere Technologies, Inc. Announces 2007 Fourth Quarter and Year End Financial Results 5Emisphere Technologies, Inc. Announces 2007 Fourth Quarter and Year End Financial Results 6Emisphere Technologies, Inc. Announces 2007 Fourth Quarter and Year End Financial Results 7Emisphere Technologies, Inc. Announces 2007 Fourth Quarter and Year End Financial Results 8
(Date:12/3/2009)...er felt overly upset by a social snubbing? Your ge...entists have long known that opium-like painkiller... but also some forms of emotional stress. Now, a n...r Markus Heilig shows that small genetic differenc...ne the intensity of people,s responses to social r...
(Date:12/3/2009)...A team of scientists from the U.S. Department of E...ard University, and the Indian Institute of Scienc...ules locate the genetic information in DNA that is...sses. The research, published in the December 1, 2...ogy , confirms that many proteins responsible for ...
(Date:12/2/2009)...HIA New study results strengthen the evidence tha...f time have an increased risk for developing color...factors. , "This provides one more reason not t...ior author Michael J. Thun, M.D., M.S., vice presi...rch at the American Cancer Society. "Colorectal ca...
Breaking Biology News(10 mins):Grooving down the helix 2Grooving down the helix 3Cigarette smoking increases colorectal cancer risk 2Cepheid Announces Accelerated Development of Flu A Panel Test 56528 1Cepheid Announces Accelerated Development of Flu A Panel Test 56528 2Cepheid Announces Accelerated Development of Flu A Panel Test 56528 3Cepheid Announces Accelerated Development of Flu A Panel Test 56528 4DNA Genotek 26apos 3Bs Oragene 26amp 3B 239679 3BANIMAL DNA Collection Kit Plays Key Role in Determining the Genetic Cause of Chiari Malformation in D 13925 1DNA Genotek 26apos 3Bs Oragene 26amp 3B 239679 3BANIMAL DNA Collection Kit Plays Key Role in Determining the Genetic Cause of Chiari Malformation in D 13925 2DNA Genotek 26apos 3Bs Oragene 26amp 3B 239679 3BANIMAL DNA Collection Kit Plays Key Role in Determining the Genetic Cause of Chiari Malformation in D 13925 3Prometheus Announces Co Pay Assistance Savings Program for LOTRONEX 28R 29 28alosteron HCl 29 Tablets 56526 1Prometheus Announces Co Pay Assistance Savings Program for LOTRONEX 28R 29 28alosteron HCl 29 Tablets 56526 2Prometheus Announces Co Pay Assistance Savings Program for LOTRONEX 28R 29 28alosteron HCl 29 Tablets 56526 3Prometheus Announces Co Pay Assistance Savings Program for LOTRONEX 28R 29 28alosteron HCl 29 Tablets 56526 4
...rauma patients, every second counts. Yet bruises, ... difficult to locate veins and administer lifesavi...orgia Institute of Technology researchers is devel...ppler ultrasound technology to find veins quickly....vessel detection," says project leader Michael Gra...
... and extreme athletes, lactic acid is poison, a wa...s to muscle fatigue, reduced performance and pain....California, Berkeley, however, tells a different s...nd athletes don,t realize it, says exercise physio...egrative biology, but endurance training teaches t...
...sweet lure of chocolate or the bitter taste of str...responses be so innate as to be hard-wired into th...lable fruit fly Drosophila, Kristin Scott and coll...Neuron experiments demonstrating just such a hard-...r a model for taste encoding in the brain that hol...
Other Biology News:Researchers develop portable 'vein finder' for faster, more accurate injections 2Researchers develop portable 'vein finder' for faster, more accurate injections 3Lactic acid not athlete's poison, but an energy source - if you know how to use it 2Lactic acid not athlete's poison, but an energy source - if you know how to use it 3Lactic acid not athlete's poison, but an energy source - if you know how to use it 4How taste response is hard-wired into the brain 2
Rabbit Anti-SERHL Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-MDMA Monoclonal Antibody, Unconjugated, Clone 3G8 from ProSci, Inc
Mouse Anti-HDV Antibody, Unconjugated from Raybiotech, Inc.
Mouse Anti-zona radiata Monoclonal Antibody, Unconjugated, Clone MN-8C4 from Abcam
Biology Products: